4.3 Review

Experimental strategies to reverse chronic renal disease

Journal

BLOOD PURIFICATION
Volume 22, Issue 5, Pages 440-445

Publisher

KARGER
DOI: 10.1159/000080790

Keywords

chronic renal injury reversal; renal replacement therapy; renin-angiotensin system; transforming growth factor-beta(1); bone morphogenic protein-7; hepatocyte growth factor

Funding

  1. NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062987] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Progression of chronic nephropathies still represents a major challenge for clinical nephrologists. Specific therapies that prevent patients from requiring dialysis or transplantation are still not available. However, recent experimental studies have demonstrated that regression of advanced lesions in the kidney can be achieved. This review summarizes the recent therapeutic advances using experimental models that might translate into novel human therapies to prevent, or significantly delay, requirement of renal replacement therapy. Copyright (C) 2004 S. Karger AG, Basel.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available